These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1490658)

  • 21. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothalamic derangement in traumatized patients: growth hormone (GH) and prolactin response to thyrotrophin-releasing hormone and GH-releasing hormone.
    De Marinis L; Mancini A; Valle D; Bianchi A; Gentilella R; Liberale I; Mignani V; Pennisi M; Della Corte F
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):741-7. PubMed ID: 10468946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity.
    Kanety H; Karasik A; Klinger B; Silbergeld A; Laron Z
    Acta Endocrinol (Copenh); 1993 Feb; 128(2):144-9. PubMed ID: 7680834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laron-type dwarfism with apparently normal high affinity serum growth hormone-binding protein.
    Buchanan CR; Maheshwari HG; Norman MR; Morrell DJ; Preece MA
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):179-85. PubMed ID: 1934534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador.
    Rosenbloom AL; Guevara Aguirre J; Rosenfeld RG; Fielder PJ
    N Engl J Med; 1990 Nov; 323(20):1367-74. PubMed ID: 2233903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children.
    Van Vliet G; Bosson D; Robyn C; Craen M; Malvaux P; Vanderschueren-Lodeweyckx M; Wolter R
    Horm Res; 1985; 22(1-2):32-45. PubMed ID: 3928475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.
    Cotterill AM; Holly JM; Taylor AM; Davies SC; Coulson VJ; Preece MA; Wass JA; Savage MO
    J Clin Endocrinol Metab; 1992 Jan; 74(1):56-63. PubMed ID: 1370165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.
    Vaccarello MA; Diamond FB; Guevara-Aguirre J; Rosenbloom AL; Fielder PJ; Gargosky S; Cohen P; Wilson K; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Jul; 77(1):273-80. PubMed ID: 7686916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC; Chen FW; Hsieh HC
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone, prolactin and thyrotrophin responses to thyrotrophin-releasing hormone in diabetic patients.
    Harrower AD
    Postgrad Med J; 1980 Jul; 56(657):481-4. PubMed ID: 6777767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of L-dopa and GHRH on GH secretion in normal men.
    Alba-Roth J; von Creytz C; Mehltretter G; Schopohl J; Müller OA; von Werder K
    J Endocrinol Invest; 1989 Dec; 12(11):783-7. PubMed ID: 2515218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethanol decreases nocturnal plasma levels of thyrotropin and growth hormone but not those of thyroid hormones or prolactin in man.
    Ekman AC; Vakkuri O; Ekman M; Leppäluoto J; Ruokonen A; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2627-32. PubMed ID: 8675588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of acute elevation of IGF-I on circulating GH, TSH, insulin, IGF-II and IGFBP-3 levels in non-endocrine short stature (NESS).
    Hanew K; Tanaka A
    J Endocrinol Invest; 2001 Jan; 24(1):1-7. PubMed ID: 11227726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 24-hour secretion of growth hormone (GH), insulin-like growth factors-I and -II (IGF-I, -II), prolactin (PRL) and thyrotropin (TSH) in young adults of normal and tall stature.
    Stratakis CA; Mastorakos G; Magiakou MA; Papavasiliou EC; Panitsa-Faflia C; Georgiadis E; Batrinos ML
    Endocr Res; 1996 Aug; 22(3):261-76. PubMed ID: 8875138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex.
    van der Lely AJ; Harris AG; Lamberts SW
    Clin Endocrinol (Oxf); 1992 Aug; 37(2):181-5. PubMed ID: 1395069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of insulin-like growth factor I (IGF-I) on growth hormone-releasing factor (GRF) and thyrotropin-releasing hormone (TRH) stimulation of growth hormone (GH) secretion in the domestic fowl (Gallus domesticus).
    Buonomo FC; Lauterio TJ; Baile CA; Daughaday WH
    Gen Comp Endocrinol; 1987 May; 66(2):274-9. PubMed ID: 3108068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical application of serum insulin-like growth factor I (IGF-I)(26-46) radioimmunoassay--with special reference to the relationship between IGF(26-46) and growth hormone secretion].
    Nakagawa Y
    Nihon Naibunpi Gakkai Zasshi; 1985 Feb; 61(2):130-44. PubMed ID: 3891431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rise in plasma growth hormone in response to exogenous LRH in Klinefelter's syndrome.
    Dickerman Z; Rachmel A; Gil-Ad I; Prager-Lewin R; Galatzer A; Laron Z
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):403-10. PubMed ID: 6797764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered growth hormone response after growth hormone releasing hormone administration in chronic renal failure.
    Garcia RV; Andrade A; Perez J; Courel M; Casanueva FF
    J Endocrinol Invest; 1991 May; 14(5):383-9. PubMed ID: 1908493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.